Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults
Study sponsor: AEON Biopharma, Inc. · AEON
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-06-19Actual
Enrollment · participants797Actual
Source updated2024-09-04Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.